← back to search

Kiran T. Thakur

NewYork–Presbyterian Hospital ·
Area of research
Microbiology · Neurology
Research interest
Research interests include Bacterial Infections and Vaccines, Long-Term Effects of COVID-19, Mosquito-borne diseases and control, and Infectious Encephalopathies and Encephalitis.
h-index
36
citations
5,642
works
244
NIH funding
primary concept
email

Recent publications

The distinctive psychopathology of NMDAR-antibody encephalitis compared with primary psychoses: an international, multicentre, retrospective phenotypic analysis
The Lancet Psychiatry 2025cited by 6position: middledoi
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis
Neuroepidemiology 2024cited by 35position: middledoi
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges
Molecular Diagnosis & Therapy 2024cited by 34position: middledoi
Clinical and Diagnostic Features of West Nile Virus Neuroinvasive Disease in New York City
Pathogens 2024cited by 15position: lastdoi
Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression
JAMA Neurology 2023cited by 18position: middledoi
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition
Journal of the Neurological Sciences 2023cited by 15position: middledoi
Neurological Events Reported after COVID‐19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
Annals of Neurology 2022cited by 107position: middledoi
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports
Cephalalgia 2022cited by 28position: middledoi
Acute flaccid myelitis: cause, diagnosis, and management
The Lancet 2020cited by 177position: middledoi
New-onset super-refractory status epilepticus
Neurology 2020cited by 46position: lastdoi
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis
mBio 2019cited by 93position: middledoi
Pediatric tuberculous meningitis: Model‐based approach to determining optimal doses of the anti‐tuberculosis drugs rifampin and levofloxacin for children
Clinical Pharmacology & Therapeutics 2015cited by 58position: middledoi
Ketogenic diet for adults in super-refractory status epilepticus
Neurology 2014cited by 187position: firstdoi
Predictors of outcome in acute encephalitis
Neurology 2013cited by 162position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Alla Guekht · University College London2 papers (2022–2022)Jennifer Frontera · NYU Langone Health2 papers (2022–2022)Arun Venkatesan · Johns Hopkins University2 papers (2013–2014)Andrea Sylvia Winkler · Technical University of Munich2 papers (2022–2022)Arina Tamborska · University of Edinburgh2 papers (2022–2022)Ettore Beghi · Mario Negri Institute for Pharmacological Research2 papers (2022–2022)Erica Westenberg · Technical University of Munich2 papers (2022–2022)Michele Santacatterina · New York University2 papers (2022–2022)James J. Sejvar · University of Colorado Denver2 papers (2022–2022)Romergryko G. Geocadin · Liechtenstein Institute2 papers (2013–2014) · 2 papers (2022–2022)Mohamed Fahmy Doheim · University of Pittsburgh Medical Center2 papers (2022–2022) · 2 papers (2022–2022)Kirsten St. George · University of Rochester Medical Center1 papers (2024–2024)Elizabeth Matthews · Northwell Health1 papers (2020–2020) · 1 papers (2019–2019)Ayham Alkhachroum · University of Miami1 papers (2020–2020)Carla Y. Kim · NewYork–Presbyterian Hospital1 papers (2024–2024)David C. Gaston · University of Alabama at Birmingham1 papers (2024–2024) · 1 papers (2015–2015)